This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Contrarian Ideas: Hedge Funds Are Selling These 10 Stocks Trading Below Target Price

2. Aastrom Biosciences, Inc. ( ASTM): Engages in developing autologous cell therapies for the treatment of severe and chronic cardiovascular diseases. Market cap at $59.1M, most recent closing price at $1.35. Of the 6 analysts that have set a target price on the stock, the lowest price target stands at $1.65. This implies a potential upside of 22.22% from current levels around $1.35. Net institutional sales in the current quarter at -2.6M shares, which represents about 5.97% of the company’s float of 43.58M shares.

 

3. BPZ Resources, Inc. ( BPZ): Engages in the exploration, development, and production of oil and natural gas in Peru and Ecuador. Market cap at $367.16M, most recent closing price at $3.14. Of the 6 analysts that have set a target price on the stock, the lowest price target stands at $4. This implies a potential upside of 27.38% from current levels around $3.14. Net institutional sales in the current quarter at -5.3M shares, which represents about 5.93% of the company’s float of 89.39M shares.

 

4. Callidus Software Inc. ( CALD): Provides sales performance management (SPM) software and services. Market cap at $169.73M, most recent closing price at $4.69. Of the 5 analysts that have set a target price on the stock, the lowest price target stands at $6. This implies a potential upside of 27.93% from current levels around $4.69. Net institutional sales in the current quarter at -1.9M shares, which represents about 6.02% of the company’s float of 31.58M shares.

 

5. MAKO Surgical Corp. ( MAKO): A medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. Market cap at $512.23M, most recent closing price at $11.15. Of the 8 analysts that have set a target price on the stock, the lowest price target stands at $13. This implies a potential upside of 16.59% from current levels around $11.15. Net institutional sales in the current quarter at -6.1M shares, which represents about 15.13% of the company’s float of 40.31M shares.

 

2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs